Regulome is accelerating the development of therapeutics and diagnostics by identifying defects in the genetic circuitry that cause or predispose to major common diseases. Regulome conducts genetics research and develops products through a proprietary, cost-effective method for rapidly identifying and analyzing the functional non-protein-coding elements that control genes. This unique capability enables Regulome to identify genes that work in concert to cause common diseases and affect the bodyâs response to drugs. Focused on discovery and development of gene regulatory information for applications in drug and diagnostic discovery and development, Regulome is applying its proprietary technology and expertise to discover the regulatory code governing genes involved in common diseases and to identify genetic regulatory defects that cause or predispose to disease. Regulome is also collaborating with leading Universities to identify and correlate specific regulatory defects with clinical phenotypes or treatment outcomes in well-characterized disease populations
